73 related articles for article (PubMed ID: 8952894)
1. [Role of type II secreted phospholipase A2 in inflammatory processes].
Jacques C; Berenbaum F
C R Seances Soc Biol Fil; 1996; 190(4):437-43. PubMed ID: 8952894
[TBL] [Abstract][Full Text] [Related]
2. Posttranscriptional effect of insulin-like growth factor-I on interleukin-1beta-induced type II-secreted phospholipase A2 gene expression in rabbit articular chondrocytes.
Jacques C; Béréziat G; Humbert L; Olivier JL; Corvol MT; Masliah J; Berenbaum F
J Clin Invest; 1997 Apr; 99(8):1864-72. PubMed ID: 9109430
[TBL] [Abstract][Full Text] [Related]
3. [Diversity of phospholipases A2 and their functions].
Bereziat G
C R Seances Soc Biol Fil; 1996; 190(4):409-16. PubMed ID: 8952891
[TBL] [Abstract][Full Text] [Related]
4. Group v secretory phospholipase A2 promotes atherosclerosis: evidence from genetically altered mice.
Bostrom MA; Boyanovsky BB; Jordan CT; Wadsworth MP; Taatjes DJ; de Beer FC; Webb NR
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):600-6. PubMed ID: 17204667
[TBL] [Abstract][Full Text] [Related]
5. Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction.
Arbibe L; Koumanov K; Vial D; Rougeot C; Faure G; Havet N; Longacre S; Vargaftig BB; Béréziat G; Voelker DR; Wolf C; Touqui L
J Clin Invest; 1998 Sep; 102(6):1152-60. PubMed ID: 9739049
[TBL] [Abstract][Full Text] [Related]
6. Induction of release of secretory nonpancreatic phospholipase A2 from human articular chondrocytes.
Pruzanski W; Bogoch E; Katz A; Wloch M; Stefanski E; Grouix B; Sakotic G; Vadas P
J Rheumatol; 1995 Nov; 22(11):2114-9. PubMed ID: 8596153
[TBL] [Abstract][Full Text] [Related]
7. Tryptophan-containing mutant of human (group IIa) secreted phospholipase A2 has a dramatically increased ability to hydrolyze phosphatidylcholine vesicles and cell membranes.
Baker SF; Othman R; Wilton DC
Biochemistry; 1998 Sep; 37(38):13203-11. PubMed ID: 9748327
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and pathophysiological roles of extracellular phospholipase A2 in inflamed sites.
Kudo I; Chang HW; Hara S; Murakami M; Inoue K
Dermatologica; 1989; 179 Suppl 1():72-6. PubMed ID: 2776931
[TBL] [Abstract][Full Text] [Related]
9. Type II secretory phospholipase A2 in cardiovascular disease: a mediator in atherosclerosis and ischemic damage to cardiomyocytes?
Niessen HW; Krijnen PA; Visser CA; Meijer CJ; Erik Hack C
Cardiovasc Res; 2003 Oct; 60(1):68-77. PubMed ID: 14522408
[TBL] [Abstract][Full Text] [Related]
10. Identification and isolation of a phospholipase A2 activating protein in human rheumatoid arthritis synovial fluid: induction of eicosanoid synthesis and an inflammatory response in joints injected in vivo.
Bomalaski JS; Fallon M; Turner RA; Crooke ST; Meunier PC; Clark MA
J Lab Clin Med; 1990 Dec; 116(6):814-25. PubMed ID: 2246557
[TBL] [Abstract][Full Text] [Related]
11. Secretory phospholipase A2 inhibitors. Possible new anti-inflammatory agents.
Tanaka K; Arita H
Agents Actions Suppl; 1995; 46():51-64. PubMed ID: 7610991
[TBL] [Abstract][Full Text] [Related]
12. The role of secretory phospholipase A2 in acute chest syndrome.
Kuypers FA; Styles LA
Cell Mol Biol (Noisy-le-grand); 2004 Feb; 50(1):87-94. PubMed ID: 15040432
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor.
Fleisch JH; Armstrong CT; Roman CR; Mihelich ED; Spaethe SM; Jackson WT; Bobbitt JL; Draheim S; Bach NJ; Dillard RD; Martinelli M; Fouts R; Snyder DW
J Pharmacol Exp Ther; 1996 Jul; 278(1):252-7. PubMed ID: 8764358
[TBL] [Abstract][Full Text] [Related]
14. Developmental maturation of baboon placental trophoblast: expression of messenger ribonucleic acid and protein levels of cytosolic and secretory phospholipases A2.
Rosenthal MD; Albrecht ED; Pepe GJ
J Clin Endocrinol Metab; 1998 Aug; 83(8):2861-7. PubMed ID: 9709960
[TBL] [Abstract][Full Text] [Related]
15. Suppression of acute experimental inflammation by antisense oligonucleotides targeting secretory phospholipase A2 (sPLA2) in vitro and in vivo experiments.
Tibes U; Röhr SP; Scheuer W; Amandi-Burgermeister E; Litters A
Adv Exp Med Biol; 1999; 469():199-207. PubMed ID: 10667331
[TBL] [Abstract][Full Text] [Related]
16. Dioleylphosphatidylglycerol inhibits the expression of type II phospholipase A2 in macrophages.
Berger A; Havet N; Vial D; Arbibe L; Dumarey C; Watson ML; Touqui L
Am J Respir Crit Care Med; 1999 Feb; 159(2):613-8. PubMed ID: 9927381
[TBL] [Abstract][Full Text] [Related]
17. Synovial fluid phospholipase A2s and inflammation.
Gonzalez-Buritica H; Khamashita MA; Hughes GR
Ann Rheum Dis; 1989 Apr; 48(4):267-9. PubMed ID: 2653242
[TBL] [Abstract][Full Text] [Related]
18. Endotoxin induces expression of type II phospholipase A2 in macrophages during acute lung injury in guinea pigs: involvement of TNF-alpha in lipopolysaccharide-induced type II phospholipase A2 synthesis.
Arbibe L; Vial D; Rosinski-Chupin I; Havet N; Huerre M; Vargaftig BB; Touqui L
J Immunol; 1997 Jul; 159(1):391-400. PubMed ID: 9200478
[TBL] [Abstract][Full Text] [Related]
19. Secretory phospholipase A2 as an index of disease activity in rheumatoid arthritis. Prospective double blind study of 212 patients.
Lin MK; Farewell V; Vadas P; Bookman AA; Keystone EC; Pruzanski W
J Rheumatol; 1996 Jul; 23(7):1162-6. PubMed ID: 8823686
[TBL] [Abstract][Full Text] [Related]
20. Regulation of extracellular phospholipase A2 activity: implications for inflammatory diseases.
Mukherjee AB; Cordella-Miele E; Miele L
DNA Cell Biol; 1992 Apr; 11(3):233-43. PubMed ID: 1567556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
